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BACKGROUND: Although current guidelines empha-
size the importance of cholesterol knowledge, little is
known about accuracy of this knowledge, factors
affecting accuracy, and the relationship of self-reported
cholesterol with cardiovascular disease (CVD).
METHODS: The 39,876 female health professionals
with no prior CVD in the Women’s Health Study were
asked to provide self-reported and measured levels of
total and high-density lipoprotein (HDL) cholesterol.
Demographic and cardiovascular risk factors were
considered as determinants of awareness and accuracy.
Accuracy was evaluated by the difference between
reported and measured cholesterol. In addition, we
examined the relationship of self-reported cholesterol
with incident CVD over 10 years.
RESULTS: Compared with women who were unaware
of their cholesterol levels, aware women (84%) had
higher levels of income, education, and exercise and
were more likely to be married, normal in weight,
treated for hypertension and hypercholesterolemia,
nonsmokers, moderate drinkers, and users of hormone
therapy. Women underestimated their total cholesterol
by 9.7 mg/dL (95% CI: 9.2–10.2); covariates explained
little of this difference (R
2 <.01). Higher levels of self-
reported cholesterol were strongly associated with
increased risk of CVD, which occurred in 741 women
(hazard ratio 1.23/40 mg/dL cholesterol, 95% CI: 1.15–
1.33). Women with elevated cholesterol who were
unaware of their level had particularly increased risk
(HR=1.88, P <. 001) relative to aware women with
normal measured cholesterol.
CONCLUSION: Women with obesity, smoking, untreat-
ed hypertension, or sedentary lifestyle have decreased
awareness of their cholesterol levels. Self-reported
cholesterol underestimates measured values, but is
strongly related to CVD. Lack of awareness of elevated
cholesterol is associated with increased risk of CVD.
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INTRODUCTION
The National Cholesterol Education Program (NCEP) initiatives
have emphasized the importance of cholesterol knowledge,
recommending routine cholesterol testing for all adults older
than 20.
1,2 Similarly, Healthy People 2010
3 aims to improve the
health of Americans through increased awareness of medical
conditions and risk factors and greater use of screening
services. Several studies
4–8 have indicated that cholesterol
awareness has increased with time but that it remains low
among the general population. Furthermore, only limited infor-
mation is available on determinants of cholesterol knowledge.
Many population studies, including the Behavioral Risk
Factor Surveillance System
4,9,10 and the American Heart
Association National Survey,
7,11 have used self-reported cho-
lesterol levels as a screening tool to assess trends in dyslipide-
mia and the performance of cardiovascular risk screening
programs. Thus, evaluation of the agreement between self-
reported and measured cholesterol levels is important. Some
studies
6,12–18 have examined the validity of self-reported
hypercholesterolemia and showed low sensitivity and frequent
underestimation. However, little is known about predictors of
accuracy and whether self-reported cholesterol levels differ
systematically from measured levels across subgroups. Fur-
thermore, in light of concerns about the accuracy of self-
reported cholesterol, the ability of self-reported cholesterol to
predict future cardiovascular disease (CVD) merits evaluation.
This study assessed awareness and determinants of cho-
lesterol knowledge among 39,876 US female health profes-
sionals in the Women’s Health Study. We evaluated the
validity of self-reported cholesterol levels and describe the
demographic characteristics and cardiovascular risk factors
influencing their accuracy. We also assessed the validity of
self-reported cholesterol in the prediction of CVD over a
period of 10 years.
METHODS
The Women’s Health Study (WHS) was a randomized, double-
blind, clinical trial of low-dose aspirin and vitamin E in the
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606primary prevention of CVD and cancer among 39,876 appar-
ently healthy women age ≥45 years. Participants were
recruited from registries of several health professions; detailed
baseline characteristics are presented elsewhere.
19–21 The trial
and its questionnaires were approved by the Human Subjects
Committee at the Brigham and Women’s Hospital.
During enrollment, between 1993 and 1996, participants
were asked on the baseline questionnaires about demographic
factors (age, race, education, profession, income, marital
status), health characteristics, and behaviors [smoking status,
alcohol use, physical activity, hormone replacement therapy
(HRT) use], cardiovascular risk factors [body mass index (BMI),
history of hypertension, diabetes mellitus, use of cholesterol-
lowering drugs], and their total cholesterol (TC) levels. Yearly
follow-up questionnaires were sent to update information on
the presence of risk factors and the occurrence of incident
cardiovascular events.
Self-reported Cholesterol Levels
Before randomization, participants were asked, “What is your
CURRENT serum cholesterol level?” Those who had their
cholesterol measured within the previous 5 years were asked to
reporttheirlevelinoneof14categories(mg/dL):<140,140–159,
160–179, 180–199, 200–219, 220–239, 240–249, 250–259,
260–269, 270–279, 280–299, 300–329, 330+, or unknown. At
48-month follow-up, women were specifically asked, “What is
your most recent high-density lipoprotein (HDL) cholesterol
level?” Awareness of cholesterol level was defined by a response
other than unknown to the above questions. Among the 6,273
womenwhoreportedthattheircholesterollevelwasunknownor
left the question blank, 6,199 (99%) reported that they did not
know their cholesterol level.
Blood Cholesterol Measurement
Participants were asked whether they would be willing to
provide a venous blood sample and were mailed blood
collection kits during the run-in phase. Blood samples were
collected in ethylenediaminetetraacetic acid (EDTA) tubes from
28,263 randomized women (71.1% of the WHS participants)
and stored in liquid nitrogen until the time of analysis. TC and
HDL levels of 27,939 women (70.1%) were measured on a
Hitachi 911 analyzer (Roche Diagnostics, IN) with reagents
from Roche Diagnostics.
21
The median time between the date of blood collection and
the date of self-reported TC was 37 days (interquartile range,
4–82 days) and that between blood collection and HDL
questionnaire was 48.2 months (43.4–53.1).
Outcome Measures
To evaluate the accuracy of the self-reported cholesterol levels
in a risk prediction analysis, we examined data from the
24,069 women who provided both self-reported TC levels and
blood samples. The participants were followed over a median of
10.1 years (interquartile range, 9.6–10.5). Annually, women (or
their next of kin) who reported the occurrence of cardiovascu-
lar events were asked for consent to release relevant medical
records, which were reviewed by an endpoint committee of
physicians. We considered the first occurrence of a major
vascular event (myocardial infarction, stroke, percutaneous
transluminal coronary angioplasty, coronary artery bypass
graft surgery, or death from cardiovascular causes) that was
reviewed and confirmed by this committee.
STATISTICAL ANALYSIS
Awareness of Cholesterol Level
We used chi-square tests to assess differences in cholesterol
awareness across categories of baseline variables. We fitted a
multivariable logistic regression model with “whether or not a
woman knew her cholesterol level” as a dichotomous outcome
variable and categorical predictors of cholesterol awareness as
independent variables. We computed the area under the
receiver–operator characteristic curve as an overall measure
of how well these variables predicted cholesterol awareness. A
separate multivariate model was fitted after exclusion of the
74 women who left blank the question on cholesterol level.
Accuracy of Self-reported Cholesterol Versus
Measured Blood Cholesterol
We used box-plots of the measured cholesterol levels within
categories of self-reported cholesterol levels to characterize the
distribution of cholesterol. We scored self-reported cholesterol
levels with the midpoint of the reported category and calculat-
ed Pearson and Spearman correlation coefficients to examine
the strength of the linear relationship between self-reported
and measured blood cholesterol levels.
To describe the level of agreement, we calculated the mean
difference between individuals’ self-reported and measured
blood cholesterol levels and tested the significance of the
difference between the measurements with a paired t-test. We
used one-way analysis of variance (ANOVA) to evaluate the
significance of differences for each characteristic and a multi-
variable linear regression model to determine whether the
discrepancy between the two measurements could be
explained by demographic characteristics and cardiovascular
risk factors.
Predictive Ability of Self-reported Cholesterol
To assess the relationship of self-reported cholesterol with the
hazard of first cardiovascular events, we considered self-
reported cholesterol and measured blood cholesterol separate-
ly and jointly in Cox proportional hazards models adjusted for
age. We used likelihood ratio tests to compare the predictive
ability of self-reported versus measured cholesterol. We also
compared categorical models with nested linear models to
assess deviation from linearity. We repeated the analysis
excluding women who were receiving cholesterol treatment
for comparison.
We fit alternative proportional hazards models for 27,938
women who had measured TC with “whether or not a woman
self-reported cholesterol” and “whether or not a woman has
elevated measured cholesterol (>240 mg/dL)” as dichotomous
predictors of CVD. We also examined the interaction between
high cholesterol and self-reporting of cholesterol. We used SAS
v.8 to perform all computations.
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Baseline characteristics N* Percent known (%) P value† Odds ratio‡ 95% CI
Age (yr)
<50 12,874 82.7 <0.001 1.00 Referent
50–59 18,379 84.9 1.04 (0.97, 1.12)
60–69 7,312 85.4 1.17 (1.06, 1.29)
70–79 1,251 85.5 1.23 (1.01, 1.49)
>80 60 76.7 0.84 (0.42, 1.69)
Race
White 37,480 84.3 0.09 1.00 Referent
Hispanic 430 84.0 1.13 (0.85, 1.51)
African American 909 82.3 1.06 (0.87, 1.29)
Asian American 541 87.3 1.35 (1.00, 1.82)
American Indian/Others 176 80.7 0.92 (0.61, 1.40)
Education
LPN/LVN 5,554 78.5 <0.001 1.00 Referent
2-yr associate’s degree RN 4,499 83.1 1.09 (0.97, 1.22)
3–yr RN diploma program 12,402 85.4 1.26 (1.15, 1.39)
BS 9,044 85.4 1.21 (1.09, 1.34)
MS 5,816 86.7 1.31 (1.16, 1.48)
Doctorate/MD 1,890 85.2 1.03 (0.87, 1.22)
Income
<$10,000 342 68.4 <0.001 1.00 Referent
$10,000–19,999 1,802 76.4 1.36 (1.04, 1.79)
$20,000–29,999 3,862 81.0 1.72 (1.32, 2.24)
$30,000–39,999 5,375 83.0 1.95 (1.50, 2.55)
$40,000–49,999 6,208 84.5 2.10 (1.61, 2.75)
$50,000–99,999 15,324 86.2 2.28 (1.74, 2.97)
>$100,000 4,678 86.8 2.20 (1.65, 2.92)
Marital status
Married 28,360 85.3 <0.001 1.00 Referent
Single 2,265 81.3 0.86 (0.76, 0.97)
Divorced 5,445 81.1 0.89 (0.82, 0.97)
Widowed 2,579 82.2 0.96 (0.84, 1.09)
Baseline history of diabetes
No 38,825 84.3 0.41 1.00 Referent
Yes 1,027 83.4 0.94 (0.78, 1.14)
Smoking status
Never 20,340 85.6 <0.001 1.00 Referent
Current 5,235 75.4 0.62 (0.57, 0.67)
Past 14,265 85.7 0.96 (0.89, 1.02)
Hypertension
Normotensive 29,535 83.7 <0.001 1.00 Referent
Untreated 4,818 82.3 0.98 (0.90, 1.07)
Treated 5,484 89.0 1.64 (1.47, 1.82)
BMI
<25.0 19,849 84.8 <0.001 1.00 Referent
25.0–<30.0 12,081 84.5 0.96 (0.90, 1.03)
≥30.0 7,126 82.3 0.91 (0.84, 0.99)
Lipid-lowering agents
No 38,608 83.8 <0.001 1.00 Referent
Yes 1,240 98.8 14.8400000 (8.39, 26.28)
Alcohol
Never/rarely 17,982 83.2 <0.001 1.00 Referent
<2 drinks/day 20,342 85.5 1.08 (1.02, 1.16)
≥2 drinks/day 1,542 80.7 0.79 (0.68, 0.92)
Exercise
Never/rarely 15,280 81.4 <0.001 1.00 Referent
<1/week 7,928 83.6 1.13 (1.05, 1.23)
1-3 times/week 12,409 86.8 1.35 (1.26, 1.46)
≥4 times/week 4,239 88.6 1.56 (1.39, 1.75)
HRT
Never 19,087 80.8 <0.001 1.00 Referent
Past 4,084 83.0 1.18 (1.07, 1.31)
Current 16,625 88.5 1.70 (1.58, 1.82)
Blood sample taken
No 11,938 79.9 <0.001 1.00 Referent
Yes 27,938 86.2 1.44 (1.35, 1.53)
C-statistic: 0.66
*Number of women in each category may not add up to total 39,876 due to missing data
†P value is from a chi-squared test
‡Odds ratios adjusted for all variables by logistic regression; 34,658 women with complete demographic information were included in the multivariable
model
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Determinants of Awareness of Cholesterol Levels
Among the 39,876 women randomized in the trial, 33,603 (84%)
self-reported their TC level, whereas 6,273 were unaware of their
cholesterol level. Among 38,147 women who responded at 48-
month follow-up, only 10,542 specified their HDL level. The mean
ages of womenwho reported and did not report their cholesterol at
baseline were 54.7 and 54.2 years, respectively. Participants who
provided blood samples also tended to be older, have higher
education and income, and to be married.
Women’s cholesterol awareness improved with age up to
80 years, degree of education (except among those with
doctorates), household income, and being married (Table 1).
There were no significant differences among racial/ethnic
groups, although confidence intervals for these effects were
wide. Profession was not included in the model because it was
highly correlated with education in this population.
Several cardiovascular risk factors were associated with
lower cholesterol awareness. Women who were current smok-
ers, obese, heavier drinkers, or living sedentary lifestyles were
less likely to report their cholesterol levels. In contrast, 89% of
women receiving treatment for hypertension and 99% of
women receiving lipid-lowering agents reported their choles-
terol levels (each P<.0001). Women with untreated hyperten-
sion had significantly less knowledge of their cholesterol levels
than did those with treated hypertension (P<.0001, not shown
in table). Women with diabetes were not more likely than wom-
en without diabetes to know their cholesterol levels (P=.41).
Interestingly, women receiving HRT were much more likely than
women who never received HRT to report their cholesterol level
(OR=1.7). Women who provided blood samples had a 44%
increased odds of cholesterol awareness. We reran the multivar-
iate analysis after exclusion of the 74 women who left blank the
question on cholesterol level, and found virtually identical results.
The area under the ROC curve
22 was 0.66, indicating that
the multivariable model has a marginal ability to discriminate
those with and without awareness of cholesterol levels.
Accuracy of Self-reported Cholesterol
Among women who provided both a cholesterol level and a blood
sample, self-reported and measured blood cholesterol were
moderately correlated. The Pearson and Spearman correlation
coefficients were 0.54 and 0.57, respectively (P<.0001), for TC
(Fig. 1) and 0.63 and 0.65, respectively (P<.0001), for HDL.
In general, women underestimated their TC level by an
average of 9.7 mg/dL (95% CI: 9.2–10.2). Almost half of the
participants (49.8%) had a difference of <20 mg/dL in either
direction between self-reported and measured cholesterol, with
32.6% of women underestimating by >20 mg/dL. For HDL,
52.7% participants had a difference of <10 mg/dL in either
direction between self-reported and measured HDL, with
37.8% overestimating by >10 mg/dL. Women systematically
overestimated their HDL by 12.4 mg/dL (95% CI: 11.7–13.2).
The magnitude of the bias was significantly higher among
divorced women and current smokers and less among obese
(BMI>30) and hypertensive women and women receiving
treatment for hypercholesterolemia (Table 2). Overall, the bias
could not be explained well by the available variables, as the
R
2 for the multivariable regression model was 0.008.
Estimates of the prevalence of hypercholesterolemia by self-
report were lower than those by objective blood measurement.
Prevalence of hypercholesterolemia (>200 mg/dl) was estimated
to be 52.9% by self-report and 59.5% by measured cholesterol.
With >240 mg/dL used as the cutoff point, the estimated
prevalence was 14.2% by self-report and 22.0% by blood test.
Predictive Value of Self-reported Cholesterol
Baseline levels of self-reported and measured blood cholesterol
each predicted the risk of incident cardiovascular outcomes in
women (Table 3). A difference of 40 mg/dL in self-reported cho-
lesterol at baseline was significantly associated with a 23%
increase in the hazard of incident cardiovascular event (95% CI:
15%–33%).
In univariate models, the log likelihood statistic was higher
for self-reported cholesterol than for measured blood choles-
terol. The two-covariate model was significantly better than
univariate models (likelihood-ratio test P<.05). On average, for
every 40 mg/dL increase in self-reported cholesterol, the
hazard of CVD increased 17% (95% CI: 7%–27%), and for
every 40 mg/dL increase in measured cholesterol, the hazard
of CVD increased 10% (95% CI: 2%–18%) after controlling for
age. With adjustment for additional traditional CVD risk
factors (included control for cholesterol-lowering agents and
HRT), no apparent confounding was noted. Upon exclusion of
women using cholesterol-lowering drugs, both self-reported
and measured cholesterol remained jointly and significantly
related to risk of CVD. The hypothesis of a linear relationship
between cholesterol and the log-hazard of CVD was not
rejected for either measured or self-reported cholesterol.
Figure 1. Distribution of measured cholesterol levels within cate-
gories of self-reported total cholesterol levels. For each of the 13
categories of self-reported cholesterol, the figure shows the inter-
quartile range of measured total cholesterol (box), the median
(horizontal line within the box), and the extreme values within 1.5
times the interquartile range from the upper or lower quartile
(vertical bars above and below the box).
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Baseline characteristics N* Mean cholesterol (mg/mL) Difference 95% CI Regression coefficient† P value
Self-reported Measured
Total 24,069 202.1 211.8 −9.7 (−10.2, −9.2)
Age (yr)
<50 7,534 191.3 201.2 −9.9 (−10.7, −9.1) Referent
50–59 11,183 204.0 214.0 −9.9 (−10.6, −9.2) −0.35 0.59
60–69 4,539 213.4 222.1 −8.7 (−9.9, −7.5) 0.42 0.63
70–79 780 212.6 222.6 −10.0 (−12.8, −7.1) −0.37 0.83
>80 33 210.6 218.7 −8.1 (−22.2, 6.0) 2.33 0.75
P‡=0.45
Race
White 22,729 202.2 211.9 −9.7 (−10.2, −9.2) Referent
Hispanic 246 202.9 210.7 −7.8 (−12.9, −2.8) 2.55 0.33
African American 441 198.3 209.8 −11.6 (−15.4, −7.7) −1.37 0.47
Asian American 344 199.5 209.4 −9.8 (−13.8, −5.9) 0.07 0.97
American Indian/others 101 203.7 211.7 −7.9 (−17.8, 1.9) 1.69 0.68
P‡=0.76
Education
LPN/LVN 2,805 204.3 215.4 −11.1 (−12.6, −9.6) Referent
2-y Associate’s degree RN 2,597 200.1 211.6 −11.5 (−13.1, −9.9) −0.46 0.70
3-y RN diploma 7,697 205.4 214.4 −8.9 (−9.8, −8.1) 1.84 0.05
BS 5,630 200.0 209.2 −9.2 (−10.2, −8.2) 1.71 0.08
MS 3,660 198.8 208.8 −10.1 (−11.3, −8.9) 1.02 0.36
Doctorate/MD 1,291 199.6 208.2 −8.6 (−10.5, −6.8) 3.38 0.02
P‡=0.01
Income
<$10,000 139 206.2 217.9 −11.7 (−19.1, −4.2) Referent
$10,000–19,999 931 210.2 222.4 −12.3 (−15.0, −9.5) −3.05 0.40
$20,000–29,999 2,159 208.1 218.0 −9.9 (−11.6, −8.2) −0.73 0.83
$30,000–39,999 3,127 205.4 214.1 −8.7 (−10.1, −7.3) 0.38 0.92
$40,000–49,999 3,782 202.4 212.2 −9.8 (−11.0, −8.6) −1.05 0.76
$50,000–99,999 9,608 199.8 209.3 −9.5 (−10.2, −8.7) −1.05 0.76
>$100,000 3,060 196.8 207.7 −10.9 (−12.2, −9.5) −2.13 0.54
P‡=0.14
Marital status
Married 17,500 201.8 210.8 −9.1 (−9.6, −8.5) Referent
Single 1,309 204.4 212.3 −8.0 (−10.0, −5.9) 0.83 0.49
Divorced 3,086 200.4 212.7 −12.3 (−13.7, −10.9) −3.34 <0.001
Widowed 1,457 208.6 219.7 −11.1 (−13.3, −8.9) −2.33 0.05
P‡<0.001
Baseline history of diabetes
No 23,470 201.9 211.6 −9.7 (−10.2, −9.2) Referent
Yes 586 207.6 217.8 −10.2 (−13.6, −6.8) −3.17 0.07
P‡=.74
Smoking status
Never 12,573 201.4 210.5 −9.1 (−9.8, −8.5) Referent
Current 2,535 204.2 217.0 −12.8 (−14.4, −11.2) −3.10 0.001
Past 8,940 202.5 212.1 −9.6 (−10.4, −8.8) −0.36 0.53
P‡<.001
Hypertension
Normotensive 17,899 199.2 209.6 −10.4 (−11.0, −9.9) Referent
Untreated 2,777 210.2 217.9 −7.6 (−9.1, −6.2) 2.27 0.01
Treated 3,372 210.5 218.0 −7.5 (−8.8, −6.1) 1.87 0.02
P‡<.001
Lipid-lowering agents
No 23,168 201.0 211.0 −10.0 (−10.5, −9.5) Referent
Yes 883 231.1 232.2 −1.1 (−3.9, 1.7) 9.22 <0.001
P‡<.001
BMI
<25 12,254 197.6 208.1 −10.5 (−11.1, −9.8) Referent
25–30 7,273 206.3 216.5 −10.2 (−11.1, −9.3) −0.20 0.74
≥30 4,074 207.5 213.8 −6.3 (−7.5, −5.1) 3.70 <0.001
P‡<.001
Alcohol
Never/rarely 10,505 203.0 212.4 −9.4 (−10.1, −8.6) Referent
<2 drinks/day 12,645 201.0 211.0 −9.9 (−10.6, −9.3) 0.41 0.47
≥2 drinks/day 913 205.7 215.4 −9.7 (−12.3, −7.2) −0.12 0.93
P‡=.58
(continued on next page)
610 Huang et al.: Self-Reported Cholesterol in Women JGIMJoint consideration of the relationship of elevated measured
cholesterol (>240 mg/dL) and knowledge of cholesterol found a
significant interaction between these two variables (P=.04).
Among women with measured cholesterol ≤240 mg/dL, those
who reported their cholesterol level had similar CVD risk to
those who did not report, whereas women with elevated
cholesterol who did not report their level had markedly
increased risk (HR=1.88, P<.0001).
DISCUSSION
Awareness of cholesterol is a cornerstone to the prevention of
CVD, yet our results show that women with one or more
important risk factor tend to have less accurate knowledge of
their cholesterol level than do women without such risk
factors. Even health professionals underestimate their choles-
terol levels and have only moderate knowledge of whether their
cholesterol is elevated. In particular, cigarette smoking, lack of
exercise, and obesity are all independently associated with
decreased awareness of cholesterol levels. Despite their much
greater risk of cardiovascular disease, women with untreated
hypertension also have less awareness of cholesterol than
those with treated hypertension, and women with diabetes are
no more knowledgeable of their cholesterol levels than those
without diabetes. Lower income and education also correlated
with decreased cholesterol awareness, yet the significant
associations of other risk factors with decreased awareness
did not change after controlling for these variables.
Population-based surveys have demonstrated that aware-
ness of cholesterol level is becoming more prevalent in the
general population. In a recent survey, 71% of US adults
reported that they had a cholesterol screening within the
previous 5 years,
9 and in a separate study, 49% of US adults
surveyed in 2001 reported that they knew their total choles-
terol.
7 In 2000, Harawa et al.
23 found that 23% of those ≥55
reported HDL, and in a 2003 American Heart Association
National Study, Mosca et al.
11 found that 29% of women
reported knowing their HDL level. In comparison to our data
obtained 10 years ago, the evidence from recent studies
indicated only a slight increase with time in levels of choles-
terol awareness.
While overall cholesterol awareness was higher among
participants in the WHS, the factors affecting awareness were
generally consistent with findings from previous studies. Two
previous studies
4,6 found poorer cholesterol knowledge among
current smokers and sedentary people. Lower income and
educational levels were also associated with decreased choles-
Table 2. (continued)
Baseline characteristics N* Mean cholesterol (mg/mL) Difference 95% CI Regression coefficient† P value
Self-reported Measured
Exercise
Never/rarely 8,706 205.4 214.0 −8.6 (−9.4, −7.8) Referent
<1 time/week 4,653 201.6 211.2 −9.6 (−10.7, −8.5) −0.73 0.33
1–3 times/week 7,847 200.2 210.8 −10.6 (−11.4, −9.7) −1.36 0.03
≥4 times/week 2,855 198.0 208.7 −10.7 (−12.1, −9.2) −1.79 0.05
P‡=.006
HRT
Never 10,744 197.8 207.6 −9.8 (−10.5, −9.1) Referent
Past 2,407 208.9 218.6 −9.7 (−11.3, −8.0) −0.38 0.69
Current 10,870 204.9 214.5 −9.6 (−10.3, −8.9) −0.05 0.93
P‡=.94
*Number of women in each category may not add up to total 24,069 due to missing data,
†Difference adjusted for all variables in linear regression with overall R
2=.008
‡Overall P value for difference between mean self-reported and blood cholesterol for each characteristic
Table 3. Relative Hazard of Cardiovascular Disease for Measured and Self-reported Cholesterol
Models Hazard ratio* P value Likelihood ratio statistic
Univariate models with level of cholesterol†
Measured 1.18 (1.10–1.25) <0.001 393.71
Self-reported 1.23 (1.15–1.33) <0.001 400.86
Average of measured and self-reported 1.28 (1.18–1.38) <0.001 405.56
Two-covariate model with level of cholesterol
‡
Self-reported 1.17 (1.07–1.27) <0.001 406.32
Measured 1.10 (1.02–1.18) 0.02
Categorical model of knowledge and measured cholesterol
§
Women with measured cholesterol≤240 and self-reported 1.00 (referent)
Women with measured cholesterol≤240 and did not report 0.94 (0.74–1.20) 0.62
Women with measured cholesterol>240 and self-reported 1.33 (1.14–1.56) <0.001
Women with measured cholesterol>240 and did not report 1.88 (1.40–2.51) <0.001
*Hazard ratio calculated for a 40 mg/dL elevation in cholesterol
†Relationship of individual cholesterol variables with the hazard of first cardiovascular events; proportional hazards model adjusted for age in 24,069
women followed for a median of 10 years, 741 developed CVD
‡Joint relationship of self-reported and measured cholesterol with the hazard of first cardiovascular events
§Proportional hazard model adjusted for age in 27,938 women followed for a median of 10 years, 867 developed CVD
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4,6,23,24 Some studies
4,8,24 also
reported lower cholesterol screening and lower knowledge
among blacks than among whites, but our results suggest that
racial differences may not be present among people with similar
occupations. Previous studies had equivocal results about the
relationships of diabetes, BMI, and alcohol consumption with
cholesterol awareness. Although one report
4,10 suggested
better knowledge of cholesterol levels among those with diabe-
tes and obesity, other reports failed to demonstrate this
association.
6,24 Thus, the differences in our results might be
because of comparable educational levels in our population and
greater knowledge of risk factors than in the general popula-
tion. Our finding of greater awareness of cholesterol among
users of HRT is consistent with other evidence of better health
care knowledge among users of HRT during the study period.
25
Previous studies with smaller samples
12–18 have examined
factors related to the validity of self-reported total cholesterol.
In a study of 192 adults, Bowlin et al.
12 found that women
underreported their cholesterol by an average of 1 mg/dL, and
men underreported it by an average of 3 mg/dL. In addition to
problems with recall, differences between reported and mea-
sured cholesterol might also be because of the natural
seasonal and diurnal variability of cholesterol or to assay var-
iability across laboratories. Our main finding on validity is that
personal characteristics had little ability to explain the discrep-
ancies between reported and measured cholesterol (R
2<.01);
observed differences were equivalently substantial across all
major subgroups of our population.
Limitations of self-reported cholesterol include errors in
recall of measured values and changes in lifestyle that may
affect cholesterol. Indeed, changes in diet or initiation of
medications affecting cholesterol such as hormone therapy
since last assessment of cholesterol would increase differences
between measured and self-reported cholesterol levels. Initia-
tion of lipid-lowering therapy would also influence cholesterol
levels, although women would presumably have their choles-
terol checked after beginning such treatment. We asked
women to report their cholesterol level if checked within the
past 5 years. A narrower window would probably have
decreased the average difference between self-reported and
measured cholesterol, although it would also likely have
introduced potential selection bias because of a greater
number of missing values. Indeed, Adult Treatment Panel III
1
recommends screening of lipid profiles every 5 years in low risk
persons, so a narrower window would be expected to selective-
ly eliminate such people. Despite the clear limitations of self-
reported cholesterol, it was a strong predictor of subsequent
cardiovascular events. Self-reported cholesterol may represent
a person’s integration of several recent cholesterol measure-
ments, and to health professionals, may be useful for risk
stratification. Furthermore, our results suggest that women
with elevated cholesterol who do not know their level may be at
a particularly increased risk of CVD, further emphasizing the
value of cholesterol knowledge.
Other limitations of our study include the restricted range of
occupations and the inclusion of women willing to participate
in this trial. This limits the generalizability of overall rates, and
the observed 84% of women who reported their TC levels is
surely higher than that of the general population. Nonetheless,
use of this population can enhance the validity of relationships
between risk factors and cholesterol knowledge because of the
more reliable reporting of other risk factors. This study also
addresses the role of cholesterol knowledge when controlled for
socioeconomic status. Furthermore, the observed 10 mg/dL
difference between self-reported and measured cholesterol
likely provides lower bounds on these discrepancies in the
general population. In addition to the above limitation, our
data on HDL were collected at 48-month follow-up; validity of
this self-report might have improved with contemporaneous
blood samples. Also, LDL awareness was not assessed in this
study because TC was still being recommended by contempo-
rary NCEP II guidelines as an initial screen for hypercho-
lesterolemia and an overall marker of cholesterol status in
patients on cholesterol therapy.
2
The results suggest that cholesterol education programs
should especially target persons with one or more additional
cardiovascular risk factors because of their greater risk of CVD
and their likely poorer knowledge of their cholesterol level.
Although there are clear limitations to the accuracy of choles-
terol knowledge, people should know that their lack of aware-
ness of elevated cholesterol is associated with an increased risk
of subsequent CVD and take steps to reduce this risk.
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